Assessment of Vaccine Herd Protection: Lessons Learned From Cholera and Typhoid Vaccine Trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34273168.
- Also identified by DOI 10.1093/infdis/jiab358 and PMC identifier 8687079.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Vaccine herd protection is the extension of the defense conferred by immunization beyond the vaccinated to unvaccinated persons in a population, as well as the enhancement of the protection among the vaccinated, due to vaccination of the surrounding population. Vaccine herd protection has traditionally been inferred from observations of disease trends after inclusion of a vaccine in national immunization schedules. Rather than awaiting outcomes of widescale vaccine deployment, earlier-stage evaluation of vaccine herd protection during trials or mass vaccination projects could help inform policy decisions about potential vaccine introduction. We describe the components, influencing factors, and implications of vaccine herd protection and discuss various methods for assessing herd protection, using examples from cholera and typhoid vaccine studies.
Medical subject headings
- Cholera
- Cholera Vaccines
- Immunity, Herd
- Typhoid Fever
- Typhoid-Paratyphoid Vaccines